Effect of tissue inhibitor of matrix metalloproteinases-1 on in vitro and in vivo adipocyte differentiation

Thrombosis Research

Volumn 124, Issue 5, 2009, Pages 578-583

  Scroyen, Ilse ^a   Cosemans, Leentje ^a   Lijnen, H Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Adipogenesis; Adipose tissue; Angiogenesis; Obesity; TIMP 1

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL DIAMETER; BODY FAT DISTRIBUTION; CELL DENSITY; CELL DIFFERENTIATION; CELL MATURATION; CELL SIZE; CONTROLLED STUDY; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN FUNCTION;

3T3 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFECTION;

EID: 70349852544     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.06.020     Document Type: Article

References (25)

1. Crandall D.L., Hausman G.J., and Kral J.G. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4 (1997) 211-232
2. Christiaens V., Scroyen I., and Lijnen H.R. Role of proteolysis in development of murine adipose tissue. Thromb Haemost 98 (2008) 290-294
3. Lijnen H.R., Maquoi E., Holvoet P., Mertens A., Lupu F., Morange P., et al. Adipose tissue expression of gelatinases in mouse models of obesity. Thromb Haemost 85 (2001) 1111-1116
4. Bouloumie A., Sengenes C., Portolan G., Galitzky J., and Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 50 (2001) 2080-2086
5. Maquoi E., Demeulemeester D., Voros G., Collen D., and Lijnen H.R. Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thromb Haemost 89 (2003) 696-704
6. Van Hul M., and Lijnen H.R. A functional role of gelatinase A in the development of nutritionally induced obesity in mice. J Thromb Haemost 6 (2008) 1198-1206
7. Demeulemeester D., Collen D., and Lijnen H.R. Effect of matrix metalloproteinase inhibition on adipose tissue development. Biochem Biophys Res Commun 329 (2005) 105-110
8. Lijnen H.R., Maquoi E., Hansen L.B., Van Hoef B., Frederix L., and Collen D. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 22 (2002) 374-379
9. Maquoi E., Munaut C., Colige A., Collen D., and Lijnen H.R. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51 (2002) 1093-1101
10. Nagase H., Visse R., and Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69 (2006) 562-573
11. Lijnen H.R., Demeulemeester D., Van Hoef B., Collen D., and Maquoi E. Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thromb Haemost 89 (2003) 249-255
12. Demeulemeester D., Scroyen I., Voros G., Snoeys J., De Geest B., Collen D., et al. Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development. Thromb Haemost 95 (2006) 1019-1024
13. Green H., and Kehinde O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7 (1976) 105-113
14. Mandrup S., Loftus T.M., MacDougald O.A., Kuhajda F.P., and Lane M.D. Obese gene expression at in vivo levels by fat pads derived from s.c. implanted 3T3-F442A preadipocytes. Proc Natl Acad Sci U S A 94 (1997) 4300-4305
15. Neels J.G., Thinnes T., and Loskutoff D.J. Angiogenesis in an in vivo model of adipose tissue development. Faseb J 18 (2004) 983-985
16. Lijnen H.R., Maquoi E., Demeulemeester D., Van Hoef B., and Collen D. Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity. Thromb Haemost 88 (2002) 345-353
17. Laitinen L. Griffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues. Histochem J 19 (1987) 225-234
18. Giles A.R. Guidelines for the use of animals in biomedical research. Thromb Haemost 58 (1987) 1078-1084
19. Alexander C.M., and Werb Z. Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro. J Cell Biol 118 (1992) 727-739
20. Kleiner D.E., and Stetler-Stevenson W.G. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218 (1994) 325-329
21. Fields G.B. Using fluorogenic peptide substrates to assay matrix metalloproteinases. Methods Mol Biol 151 (2001) 495-518
22. Yoshiji H., Kuriyama S., Miyamoto Y., Thorgeirsson U.P., Gomez D.E., Kawata M., et al. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32 (2000) 1248-1254
23. Cuaz-Pérolin C., Jguirim I., Larigauderie G., Jlassi A., Furman C., Moreau M., et al. Apolipoprotein E knockout mice overexpressing human tissue inhibitor of metalloproteinase 1 are protected against aneurysm formation but not against atherosclerotic plaque development. J Vasc Res 43 (2006) 493-501
24. Van Roy M., Wielockx B., Baker A., and Libert C. The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon γ antitumor therapy. Cancer Gene Therapy 14 (2007) 372-379
25. Ikenaka Y., Yoshiji H., Kuriyama S., Yoshii J., Noguchi R., Tsujinoue H., et al. Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model. Int J Cancer 105 (2003) 340-346